Univest
Univest
  • Markets

Nifty Pharma Prediction for Tomorrow (18 Nov 2026): Index Steadies, Up 0.21% After Monday’s Fall

  • November 17, 2026
  • Posted by: Kunal Singla
  • Category: Uncategorized
No Comments
Nifty Pharma Prediction for Tomorrow (18 Nov 2026): Index Steadies, Up 0.21% After Monday's Fall

Quick Answer: The Nifty Pharma prediction for tomorrow is neutral for Wednesday, 18 November 2026. Nifty Pharma rose 0.21 percent to 28,157.10 on Tuesday, with first support near 28,040.97 and first resistance near 28,260.92. A hold above 28,040.97 keeps the setup steady, while a fall below it puts 27,924.83 in view.

Pharma stocks steadied on Tuesday after a sharp fall on Monday, with the index recovering from an early dip to close slightly higher. This Nifty Pharma forecast for tomorrow is built from Tuesday’s verified closing prices and is meant for the session on Wednesday, 18 November 2026.

The weekly Nifty expiry has passed, and the next monthly expiry falls on Monday, 23 November, so options positioning is worth reading ahead of the session. Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, are tracking US pricing, regulation and the rupee for the Nifty Pharma prediction for tomorrow.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Nifty Pharma Prediction for Tomorrow: Key Levels for 18 Nov 2026
  • Today’s Market Recap
  • Nifty Pharma Forecast for Tomorrow: Bull, Base and Bear Cases
  • What Is Driving the Nifty Pharma Outlook for Tomorrow
  • Stocks and Triggers to Watch in the Nifty Pharma Space
  • Risks to the Nifty Pharma Prediction for Tomorrow
  • Analyst View: Ankit Jaiswal and Kunal Singla
  • Why This Is a Prediction for Wednesday
  • Bottom Line for Wednesday’s Session
  • Frequently Asked Questions
    • What is the Nifty Pharma prediction for tomorrow?
    • What are the support and resistance levels for Nifty Pharma tomorrow?
    • Why did Nifty Pharma rise on Tuesday?
    • What will move Nifty Pharma on Wednesday?
    • Is Nifty Pharma bullish or bearish for tomorrow?
    • Is this a buy or sell call?

Nifty Pharma Prediction for Tomorrow: Key Levels for 18 Nov 2026

The Nifty Pharma prediction for tomorrow for Wednesday, 18 November 2026 uses classic pivot levels calculated from Tuesday’s high of 28,248.60, low of 28,028.65 and close of 28,157.10, with support below the last price and resistance above it. These are the Nifty Pharma support and resistance levels Univest’s analysts are watching.

Trend Support 1 Support 2 Resistance 1 Resistance 2
Sideways 28,040.97 27,924.83 28,260.92 28,364.73
Close Change Open High Low Previous close
28,157.10 +0.21% 28,066.35 28,248.60 28,028.65 28,098.40

Today’s Market Recap

Tuesday’s session sets the base for the Nifty Pharma prediction for tomorrow, and the points below show how the day unfolded.

  • Nifty Pharma rose 0.21 percent to 28,157.10 on Tuesday, opening below the previous close of 28,098.40 at 28,066.35 and closing about 92 points below its high of 28,248.60. It dipped to 28,028.65, below the previous close of 28,098.40, before recovering. It gained less than the Nifty 50’s 0.38 percent.
  • The index rose 0.21 percent after falling 1.53 percent on Monday, so the rebound was small compared with the previous fall.
  • The Nifty 50 rose 0.38 percent to 25,387.40 and the Sensex rose 0.52 percent to 82,532.19.
  • Sector moves were mixed. The Nifty Auto index rose 0.72 percent, the Nifty Metal index rose 0.58 percent and the Nifty Pharma index rose 0.21 percent, while the Nifty IT index fell 0.90 percent and the Nifty FMCG index fell 0.20 percent.
  • Most active among the stocks Univest tracked: HDFC Bank (about 34.9 million shares), Zee Entertainment (about 16.0 million), Reliance Industries (about 15.9 million) and ICICI Bank (about 15.3 million).

Nifty Pharma Forecast for Tomorrow: Bull, Base and Bear Cases

The Nifty Pharma prediction for tomorrow can play out three ways on Wednesday, depending on whether the levels above hold.

  • Bullish case: A move and hold above 28,260.92 would point toward 28,364.73, with volume confirming the push.
  • Base case: Trade between 28,040.97 and 28,260.92 keeps the Nifty Pharma outlook for tomorrow range-bound, which Univest’s analysts treat as the default if no fresh trigger appears.
  • Bearish case: A fall below 28,040.97 would bring 27,924.83 into focus and weaken the near-term tone.

What Is Driving the Nifty Pharma Outlook for Tomorrow

  • The index opened at 28,066.35, below Monday’s close of 28,098.40, dipped to 28,028.65 and then rose to a high of 28,248.60.
  • The gain of 0.21 percent was smaller than the Nifty 50’s 0.38 percent, so pharma lagged the market.
  • The close of 28,157.10 sits about 92 points below the high, so some of the intraday rise was given back.

Pharma stocks respond to US generic pricing, regulatory news and the rupee. Tuesday’s specific trigger was not independently confirmed. The Nifty Pharma prediction for tomorrow therefore leans on the price data and the levels above.

Stocks and Triggers to Watch in the Nifty Pharma Space

Univest’s analysts watch the large drug makers inside the index and US pricing commentary. Kunal Singla suggests that a small rebound after a sharp fall shows selling pressure easing but not yet reversing.

F&O and options context: For the 23 November monthly expiry, the Nifty options data shows a put-call ratio of approximately 1.09, with call open interest highest at the 25,500 strike and put open interest highest at the 25,000 strike, followed by 25,200. India VIX fell 1.08 percent to 15.51. Ankit Jaiswal suggests reading the Nifty Pharma outlook for tomorrow alongside these strikes, since heavy open-interest strikes often act as reference zones for the index.

These are educational views, not buy calls, and each should be checked against your own risk plan before acting.

Risks to the Nifty Pharma Prediction for Tomorrow

These are the main ways the Nifty Pharma prediction for tomorrow could turn out wrong.

  • A fresh regulatory or pricing headline can move the group quickly.
  • The rebound recovered only a small part of Monday’s 1.53 percent fall.
  • A strong rupee can reduce export earnings for drug makers.

No level in this Nifty Pharma prediction for tomorrow is guaranteed to hold, and a single headline can invalidate it.

Analyst View: Ankit Jaiswal and Kunal Singla

On the Nifty Pharma prediction for tomorrow, Kunal Singla suggests that a close above 28,248.60 would show the rebound gaining strength, while the index still sits well below Monday’s earlier high.

Ankit Jaiswal flags that the early dip to 28,028.65 followed by a rise to 28,248.60 shows two-way trade, so the range between them is the level to watch.

Both analysts stress that the Nifty Pharma prediction for tomorrow is a view built on levels and data, not a forecast of returns.

Why This Is a Prediction for Wednesday

This Nifty Pharma prediction for tomorrow is published on Tuesday, 17 November 2026, after the close, using Tuesday’s data, for the next trading session on Wednesday, 18 November 2026. Exchanges are open as usual on Wednesday.

Track the Nifty Pharma Space on Univest Screeners

Download the Univest iOS App or Univest Android App to get daily market recommendations and insightful research pieces.

Bottom Line for Wednesday’s Session

The Nifty Pharma prediction for tomorrow leans neutral, with US pricing, regulation and the rupee as the variables to track. Ankit Jaiswal and Kunal Singla will revisit the view after Wednesday’s opening trade.

Disclaimer: Investments in securities are subject to market risk. Read all related documents carefully before investing. The information provided here is for educational purposes only and does not constitute investment advice. Univest is a SEBI-registered investment adviser (Registration No. INH000013776). Past performance is not indicative of future returns.

Frequently Asked Questions

What is the Nifty Pharma prediction for tomorrow?

Ans. The Nifty Pharma prediction for tomorrow is neutral for Wednesday, 18 November 2026. Nifty Pharma rose 0.21 percent to 28,157.10 on Tuesday, and Univest’s analysts watch 28,040.97 as support and 28,260.92 as resistance.

What are the support and resistance levels for Nifty Pharma tomorrow?

Ans. For the Nifty Pharma prediction for tomorrow, support 1 is 28,040.97 and support 2 is 27,924.83, while resistance 1 is 28,260.92 and resistance 2 is 28,364.73. These are classic pivot levels calculated from Tuesday’s high of 28,248.60, low of 28,028.65 and close of 28,157.10.

Why did Nifty Pharma rise on Tuesday?

Ans. The Nifty Pharma index rose slightly on Tuesday after a 1.53 percent fall on Monday, dipping to 28,028.65 early and then recovering to settle at 28,157.10. The specific trigger was not independently confirmed, so the move is best read through the price data: a high of 28,248.60, a low of 28,028.65 and a close of 28,157.10.

What will move Nifty Pharma on Wednesday?

Ans. US generic pricing, regulatory news, the rupee and the Nifty 50 are the usual drivers. Each of these feeds into the Nifty Pharma prediction for tomorrow for the session.

Is Nifty Pharma bullish or bearish for tomorrow?

Ans. The tone of the Nifty Pharma prediction for tomorrow is neutral, with the trend marked sideways. A hold above 28,040.97 keeps the setup steady, a close above 28,260.92 would strengthen it, and a fall below 28,040.97 would weaken it.

Is this a buy or sell call?

Ans. No. This is an educational outlook from Univest’s research team, not a buy or sell call. Readers should check any view against their own risk plan, and past price moves do not guarantee future returns.



Nifty Pharma NIFTY Pharma Prediction for Tomorrow Pharma Stocks
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply